Related Experiment Video
Updated: Jun 8, 2025

Author Spotlight: Improving the Production of Self-Assembling Fibers and Peptide Hydrogels for Superior Biocompatibility
Published on: September 6, 2024
Host-Guest Adduct as a Stimuli-Responsive Prodrug: Enzyme-Triggered Self-Assembly Process of a Short Peptide Within
Sandip Sarkar1, Atin Chatterjee1, Dohyun Kim2
1Department of Chemical Sciences and Center for Advanced Functional Material, Indian Institute of Science Education and Research (IISER) Kolkata, Mohanpur, 741246, India.
Abstract:
To address the issue of nonspecific biodistribution of a chemotherapeutic drug, stable [2]pseudorotaxane complexes (PK@CAOPP and PR@CAOPP) are used to demonstrate a proof of concept. Cationic -PPh3 + moiety in CAOPP allows specific localization of the PK@CAOPP/ PR@CAOPP in the mitochondrial membrane (MM). Electrostatic interaction between the cationic LysinePK or ArgininePR moiety and the negatively charged phosphoesterCAOPP functionality in CAOPP favours strong adduct formation. The ALP-induced hydrolytic cleavage of the phosphoester moiety in cancer cells triggers dephosphorylation and releases PK/ PR moiety from PK@CAOPP/PR@CAOPP. PK or PR, derived from the Phe-Phe dipeptide, formed fibril-like molecular aggregates in the MM to induce dysfunction, depolarization, ROS generation and apoptotic MCF7 cell death. Such phenomena were not observed in ALP-negative HEK293 normal cells. These propositions were confirmed through control studies using NBDK and PE, other guest molecules. Smaller size and inclusion of the short peptides (PK or PR) within the hydrophobic interior of CAOPP, were attributed to their stability in blood serum. Thus, we have demonstrated the use of supramolecular adducts as a potential therapeutic option for treating cancer cells without affecting healthy cells. The efficacy was also established with an in-vivo MCF7 tumour xenograft model using Balb/c nude mice.
Insights
This study introduces novel supramolecular adducts for targeted cancer therapy. These complexes deliver chemotherapy drugs specifically to cancer cells, inducing apoptosis without harming healthy cells.
Area of Science:
- Supramolecular Chemistry
- Nanomedicine
- Cancer Therapeutics
Background:
- Nonspecific biodistribution of chemotherapeutic drugs limits treatment efficacy and increases side effects.
- Targeted drug delivery systems are crucial for improving cancer treatment outcomes.
- Mitochondrial membrane localization offers a promising strategy for selective cancer cell targeting.
Purpose of the Study:
- To develop stable [2]pseudorotaxane complexes for targeted cancer therapy.
- To demonstrate the selective delivery and release of therapeutic agents in cancer cells.
- To evaluate the efficacy of supramolecular adducts in inducing cancer cell death and in vivo tumor reduction.
Main Methods:
- Synthesis of stable [2]pseudorotaxane complexes (PK@CAOPP and PR@CAOPP) with specific targeting moieties.
- Utilizing electrostatic interactions for targeted localization to the mitochondrial membrane (MM).
- Investigating ALP-induced hydrolytic cleavage for drug release and subsequent apoptosis induction in cancer cells (MCF7) versus normal cells (HEK293).
- In vivo efficacy studies using MCF7 tumor xenograft models in Balb/c nude mice.
Main Results:
- PK@CAOPP and PR@CAOPP complexes demonstrated specific localization to the mitochondrial membrane via electrostatic interactions.
- Alkaline phosphatase (ALP) in cancer cells triggered the release of active moieties (PK/PR), leading to fibril formation, MM dysfunction, ROS generation, and apoptosis.
- No significant effects were observed in ALP-negative normal cells, confirming selectivity.
- In vivo studies showed significant reduction in tumor volume in the xenograft model.
Conclusions:
- Supramolecular adducts offer a viable strategy for targeted cancer chemotherapy, minimizing off-target effects.
- The developed pseudorotaxane system enables selective drug release and potent induction of cancer cell apoptosis.
- This approach holds potential for developing safer and more effective cancer therapeutics.
Related Concept Videos
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Caspases
The Extrinsic Apoptotic Pathway
Mitochondrial Precursor Proteins
Most of the mitochondrial...
The Intrinsic Apoptotic Pathway
Apoptosis

